
CYSTIC FIBROSIS MUTATION SPECTRUM
IN NORTH MACEDONIA:
A STEP TOWARD PERSONALIZED THERAPY Terzic M1, Jakimovska M1, Fustik S2, Jakovska T3, Sukarova-Stefanovska E1, Plaseska-Karanfilska D1,* *Corresponding Author: Professor Dijana Plaseska-Karanfilska, MD, PhD, Research Center for Genetic
Engineering and Biotechnology “Georgi D.Efremov,” Macedonian Academy of Sciences and Arts,
Av. Krste Misirkov 2, 1000 Skopje, Republic of North Macedonia. Tel: +389-23-235-400/264.
E-mail: dijana@manu. edu.mk page: 35
|
REFERENCES
1. Ratjen F, Doring G. Cystic fibrosis. Lancet. 2003;
361(9358): 681-689.
2. O’Sullivan BP, Freedman SD. Cystic fibrosis. Lancet.
2009; 373(9678): 1891-1904.
3. Cutting GR. Cystic fibrosis genetics: From molecular
understanding to clinical application. Nat Rev Genet.
2015; 16(1): 45-56.
4. Castellani C, Cuppens H, Macek M Jr, Cassiman JJ,
Kerem E, Durie P, et al. Consensus on the use and
interpretation of cystic fibrosis mutation analysis in
clinical practice. J Cyst Fibros. 2008; 7(3): 179-196. 5. Dequeker E, Stuhrmann M, Morris MA, Casals T, Castellani
C, Claustres M, et al. Best practice guidelines
for molecular genetic diagnosis of cystic fibrosis and
CFTR-related disorders--updated European recommendations.
Eur J Hum Genet. 2009; 17(1): 51-65.
6. Viviani L, Zolin A, Mehta A, Olesen HV. The European
Cystic Fibrosis Society Patient Registry: Valuable
lessons learned on how to sustain a disease registry.
Orphanet J Rare Dis. 2014; 9(1): 81-94.
7. Maiuri L, Raia V, Kroemer G. Strategies for the etiological
therapy of cystic fibrosis. Cell Death Differ.
2017; 24(11): 1825-1844.
8. Noveski P, Madjunkova S, Mircevska M, Plaseski T,
Filipovski V, Plaseska-Karanfilska D. SNaPshot assay
for the detection of the most common CFTR mutations
in infertile men. PloS One. 2014; 9(11): e112498.
9. Fustik S, Jakovska T, Plaseska-Karanfilska D. Hyponatremic
dehydration and metabolic alkalosis as
dominant manifestation in cystic fibrosis infants with
mild phenotype – a case series. Srpski Arhiv za Celokupno
Lekarstvo. 2018; 146(9-10): 581-583.
10. Simova L, Williams C, Efremov GD, Gordova-Muratovska
A, Sustic S, Watson EK, et al. δ F508 frequency
and associated haplotypes near the cystic fibrosis locus
in the Yugoslav population. Hum Genet. 1990; 85(4):
432-433.
11. Petreska L, Koceva S, Plaseska D, Chernick M, Gordova-
Muratovska A, Fustic S, et al. Molecular basis
of cystic fibrosis in the Republic of Macedonia. Clin
Genet. 1998; 54(3): 203-209.
12. Radivojevic D, Djurisic M, Lalic T, Guc-Scekic M,
Savic J, Minic P, et al. Spectrum of cystic fibrosis
mutations in Serbia and Montenegro and strategy for
prenatal diagnosis. Genet Test. 2004; 8(3): 276-280.
13. Festini F, Taccetti G, Repetto T, Mannini C, Neri S,
Bisogni S, et al. Incidence of cystic fibrosis in the
Albanian population. Pediatr Pulmonol. 2008; 43(11):
1124-1129.
14. Kanavakis E, Efthymiadou A, Strofalis S, Doudounakis
S, Traeger-Synodinos J, Tzetis M. Cystic fibrosis
in Greece: Molecular diagnosis, haplotypes, prenatal
diagnosis and carrier identification amongst high-risk
individuals. Clin Genet. 2003; 63(5): 400-409.
15. Dobra R, Edmondson C, Hughes D, Martin I, Davies
JC. Potentiators and correctors in paediatric cystic
fibrosis patients: A narrative review. Paediatr Drugs.
2018; 20(6): 555-566.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|